Patents by Inventor Marina Kalujny

Marina Kalujny has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID STATE FORMS OF SITAGLIPTIN SALTS
    Publication number: 20120316175
    Abstract: Solid state forms of Sitagliptin salts, processes for preparing the solid state forms, and pharmaceutical compositions thereof, are provided.
    Type: Application
    Filed: August 20, 2012
    Publication date: December 13, 2012
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Gideon PILARSKI, Nurit PERLMAN, Ariel MITTELMAN, Nada KOSUTIC HULITA, Marina KALUJNY, Revital RAMATY
  • Solid state forms of sitagliptin salts
    Patent number: 8329696
    Abstract: Solid state forms of Sitagliptin salts (e.g. Sitagliptin sulfate, Formula I), processes for preparing the solid state forms, and pharmaceutical compositions thereof, are provided. These compounds are of a class of dipeptidyl peptidase IV enzyme inhibitors which are useful, for example, for the manufacture of a medicament for the treatment of type 2 diabetes mellitus.
    Type: Grant
    Filed: March 29, 2010
    Date of Patent: December 11, 2012
    Assignee: Teva Pharmaceuticals Industries Ltd.
    Inventors: Gideon Pilarski, Nurit Perlman, Ariel Mittelman, Nada Kosutic Hulita, Marina Kalujny, Revital Ramaty
  • SOLID STATE FORMS OF SITAGLIPTIN SALTS
    Publication number: 20100249140
    Abstract: Solid state forms of Sitagliptin salts, processes for preparing the solid state forms, and pharmaceutical compositions thereof, are provided.
    Type: Application
    Filed: March 29, 2010
    Publication date: September 30, 2010
    Applicant: Teva Pharmaceutical Industries Ltd.
    Inventors: Gideon PILARSKI, Nurit PERLMAN, Ariel MITTELMAN, Nada KOSUTIC HULITA, Marina KALUJNY, Revital RAMATY
  • Crystalline form of sitagliptin
    Publication number: 20090221595
    Abstract: A Sitagliptin crystalline form characterized by PXRD pattern having any 5 peaks selected from the group consisting of 7.4, 11.5, 16.7, 17.7, 18.9, 24.1, 24.5, 27.0, 28.5 and 28.8±0.2 degrees 2-theta, wherein any combination of peaks selected includes the peak at 7.4±0.2 degrees two theta, processes for preparing said Sitagliptin crystalline form, and pharmaceutical compositions thereof, are provided.
    Type: Application
    Filed: November 25, 2008
    Publication date: September 3, 2009
    Inventors: Nurit Perlman, Revital Ramaty, Eli Lancry, Marina Kalujny
  • Processes for the preparation of a linezolid intermediate, linezolid hydroxide
    Publication number: 20090093631
    Abstract: Provided are methods for the enantiomeric purification of Linezolid hydroxide, comprising providing a solution or a slurry of Linezolid hydroxide and a solvent selected from alcohols and ketones and crystallizing Linezolid hydroxide from the solution or slurry to obtain Linezolid hydroxide with a low content of S isomer.
    Type: Application
    Filed: September 5, 2008
    Publication date: April 9, 2009
    Inventors: Ben-Zion Dolitzky, Nurit Perlman, Marina Kalujny